Lantern Pharma Inc. Insider Trading
LTRN
Insiders bought 200K on the open market and sold nothing.
Get an email when LTRN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| May 12 | Lee Troy Schalop Director | Bought | 48,544 | $2.06 | 100K | New | Form 4 |
| May 12 | D Jeffrey Keyser Director | Bought | 48,544 | $2.06 | 100K | 106% | Form 4 |
| Jun 13, 2025 | Bios Fund II QP, LP Large holder | SoldNo plan 5 parts | 40,000 | $3.09 average | 124K | 3.6% | Form 4 |
| Jun 13, 2025 | BP Directors, LP Large holder | SoldNo plan 5 parts | 40,000 | $3.09 average | 124K | 3.6% | Form 4 |
| Jun 10, 2025 – Jun 12, 2025 | Bios Fund I, LP Large holder | SoldNo plan 15 parts | 61,613 | $3.38 average | 208K | 5.2% | Form 4 |
| Jun 10, 2025 – Jun 12, 2025 | Cavu Advisors, LLC Large holder | SoldNo plan 15 parts | 61,613 | $3.38 average | 208K | 5.2% | Form 4 |
| May 27, 2025 – May 29, 2025 | Bios Advisors GP, LLC Large holder | SoldNo plan 15 parts | 56,237 | $2.99 average | 168K | 4.6% | Form 4 |
| May 27, 2025 – May 29, 2025 | Cavu Advisors, LLC Large holder | SoldNo plan 15 parts | 56,237 | $2.99 average | 168K | 4.6% | Form 4 |
- May 12Lee Troy SchalopDirector · bought 48,544 at $2.06100KNew position
- May 12D Jeffrey KeyserDirector · bought 48,544 at $2.06100K106% of stake
- Jun 13, 2025No planBios Fund II QP, LPLarge holder · sold 40,000 at avg $3.09124K3.6% of stake
- Jun 13, 2025No planBP Directors, LPLarge holder · sold 40,000 at avg $3.09124K3.6% of stake
- Jun 10, 2025 – Jun 12, 2025No planBios Fund I, LPLarge holder · sold 61,613 at avg $3.38208K5.2% of stake
- Jun 10, 2025 – Jun 12, 2025No planCavu Advisors, LLCLarge holder · sold 61,613 at avg $3.38208K5.2% of stake
- May 27, 2025 – May 29, 2025No planBios Advisors GP, LLCLarge holder · sold 56,237 at avg $2.99168K4.6% of stake
- May 27, 2025 – May 29, 2025No planCavu Advisors, LLCLarge holder · sold 56,237 at avg $2.99168K4.6% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with LTRN
Held by ETFs
LTRN is in 1 US ETF. The largest of them, with LTRN's weight in each:
Spot a number that looks wrong? Check it in LTRN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing LTRN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.